Public Release: 

Fatty liver disease is common

Linked with certain risk factors in liver transplant recipients


Researchers have characterized the prevalence and risk factors of fatty liver disease in patients who undergo liver transplantation. The findings, which are published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases, could have important implications for safeguarding transplant recipients' health.

Steatosis -- when the liver becomes infiltrated with fat--occurs frequently after liver transplantation, but little is known about its actual prevalence in transplant recipients, which risk factors are involved, or what effects the condition has on patients' survival. To investigate, Irena Hejlova, MD, of the Institute for Clinical and Experimental Medicine in Prague, and her colleagues retrospectively examined liver biopsies and patient survival data on 548 liver transplant recipients.

Steatosis was found in 309 patients (56.4 percent), including 93 patients (17.0 percent) with significant steatosis. The prevalence increased from 30.3 percent at 1 year to 47.6 percent at 10 years after liver transplantation. When the investigators looked at patients' pre-transplant characteristics, they found that high body mass index and cirrhosis caused by alcohol consumption were linked with an increased risk of developing steatosis. Regarding patients' post-transplant characteristics, high body mass index, elevated blood triglycerides, alcohol consumption, and type 2 diabetes were linked with steatosis. Post-transplant steatosis was not associated with worse patient survival within several years, but the long-term survival of patients with significant steatosis tended to be worse.

"Our study is the first to describe the occurrence, evolution, and significance of fatty liver in a large unselected population of European liver transplant recipients," said Dr. Hejlova. "Occurrence of fatty liver could indicate those patients whose long-term survival might be impaired. Therefore obesity should be avoided and patients should be encouraged to increase their physical activity. Screening and treatment of diabetes and hyperlipidemia should also be performed, and naturally, liver transplant recipients should abstain from alcohol consumption."


Full citation: "Prevalence and Risk Factors of Steatosis after Liver Transplantation and Patient Outcomes." Irena Hejlova, Eva Honsova, Eva Sticova, Vera Lanska, Tomas Hucl, Julius Spicak, Milan Jirsa, and Pavel Trunecka. Liver Transplantation; (DOI: 10.1002/lt.24393).


Author Contact:

Veronika Velcová
Press office

Martin Kutil
PR and marketing
00420-23605-2511, 00420-731-190-833.

About the Journal

Liver Transplantation is published by Wiley on behalf of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. Since the first application of liver transplantation in a clinical situation was reported more than twenty years ago, there has been a great deal of growth in this field and more is anticipated. As an official publication of the AASLD and the ILTS, Liver Transplantation delivers current, peer-reviewed articles on surgical techniques, clinical investigations and drug research -- the information necessary to keep abreast of this evolving specialty. For more information, please visit

About Wiley

Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The Company's website can be accessed at

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.